We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
+32.58%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
AUM
$4.62B
AUM Growth
+$1.1B
Cap. Flow
+$70.8M
Cap. Flow %
1.53%
Top 10 Hldgs %
22.6%
Holding
123
New
3
Increased
67
Reduced
50
Closed
3

Top Buys

Rank Stock Value
1
WDFC icon
WD-40
WDFC
+$18.9M
2
AXON
Axon Enterprise
AXON
+$17.8M
3
ESE icon
ESCO Technologies
ESE
+$12M
4
PLMR icon
Palomar
PLMR
+$11.6M
5
BCPC
Balchem Corp
BCPC
+$10.5M

Sector Composition

Rank Sector Weight
1 Technology 31.5%
2 Industrials 21.87%
3 Healthcare 19.11%
4 Consumer Discretionary 8.67%
5 Financials 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOVT icon
26
Novanta
NOVT
$5.92B
$57.7M 1.25%
540,589
+100,376
+23% +$9.33M
SITE icon
27
SiteOne Landscape Supply
SITE
$4.53B
$57.3M 1.24%
503,056
+14,593
+3% +$1.36M
QTWO icon
28
Q2 Holdings
QTWO
$3.92B
$57.2M 1.24%
666,862
+19,139
+3% +$1.47M
TXRH icon
29
Texas Roadhouse
TXRH
$13.7B
$56M 1.21%
1,065,517
-61,619
-5% -$3M
JJSF icon
30
J&J Snack Foods
JJSF
$1.71B
$53.8M 1.16%
422,904
+54,692
+15% +$6.87M
AAON icon
31
Aaon
AAON
$7.77B
$53.1M 1.15%
1,466,336
+44,894
+3% +$1.51M
EPAY
32
DELISTED
Bottomline Technologies Inc
EPAY
$52.1M 1.13%
1,026,195
+34,455
+3% +$1.54M
TCMD icon
33
Tactile Systems Technology
TCMD
$665M
$51.8M 1.12%
1,251,093
+39,465
+3% +$1.85M
INTU icon
34
Intuit
INTU
$89B
$51.5M 1.12%
173,925
-1,433
-0.8% -$393K
MRTN icon
35
Marten Transport
MRTN
$1.22B
$49.7M 1.08%
2,961,825
+77,922
+3% +$1.22M
EXLS icon
36
EXL Service
EXLS
$5.29B
$48.6M 1.05%
3,836,440
+130,245
+4% +$1.54M
PRLB icon
37
Protolabs
PRLB
$2.13B
$47.3M 1.02%
420,905
+14,464
+4% +$1.48M
ANSS
38
DELISTED
Ansys
ANSS
$47M 1.02%
161,231
-1,799
-1% -$479K
IDXX icon
39
Idexx Laboratories
IDXX
$46.2B
$47M 1.02%
142,426
-2,951
-2% -$854K
POOL icon
40
Pool Corp
POOL
$7.5B
$45.6M 0.99%
167,648
-3,320
-2% -$769K
CPRT icon
41
Copart
CPRT
$27.5B
$45.3M 0.98%
2,175,236
-42,980
-2% -$863K
ESE icon
42
ESCO Technologies
ESE
$7.92B
$44.3M 0.96%
523,984
+151,873
+41% +$12M
EVOP
43
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$43.8M 0.95%
1,918,719
+315,663
+20% +$6.28M
GMED icon
44
Globus Medical
GMED
$11.2B
$43.3M 0.94%
906,518
+24,876
+3% +$1.2M
FISV
45
Fiserv Inc
FISV
$27.9B
$42.5M 0.92%
435,105
-3,068
-0.7% -$309K
PLUS icon
46
ePlus
PLUS
$2.34B
$42.1M 0.91%
1,191,772
+36,930
+3% +$1.26M
PETQ
47
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$42M 0.91%
1,204,883
+37,005
+3% +$1.04M
GPN icon
48
Global Payments
GPN
$22.8B
$41.3M 0.89%
243,512
-1,788
-0.7% -$298K
BR icon
49
Broadridge
BR
$19B
$41.1M 0.89%
326,011
-1,633
-0.5% -$189K
ORLY icon
50
O'Reilly Automotive
ORLY
$76.3B
$41.1M 0.89%
1,463,130
-32,865
-2% -$859K

Similar funds

Geneva Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Geneva Capital Management held 123 positions worth $4.62B, up 31% from $3.52B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 4.9%. Geneva Capital Management opened 3 new positions and exited 3, leaving the 123-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Geneva Capital Management's largest Q2 2020 buy was Axon Enterprise: 220,073 shares worth $21.6M.
  • Geneva Capital Management added most to WD-40 in Q2 2020, an estimated $18.9M increase.
  • Geneva Capital Management's biggest Q2 2020 reduction was Paycom, cutting an estimated $31.2M.
  • Geneva Capital Management fully exited Ligand Pharmaceuticals in Q2 2020, selling an estimated $17.8M.
  • Geneva Capital Management's ten largest holdings make up 23% of its $4.62B portfolio in Q2 2020.
  • Geneva Capital Management opened 3 new positions and closed 3 in Q2 2020.
  • Geneva Capital Management's portfolio value rose 31% quarter-over-quarter to $4.62B.

Based on Geneva Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.